ZyVersa Therapeutics to Go Public Via Merger with Larkspur Health Acquisition Corp (LSPR) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ZyVersa Therapeutics to Become a Publicly Traded Biopharma Company via Merger with Larkspur Health Acquisition Corp streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ZyVersa is a clinical stage biopharmaceutical company developing first-in-class product candidates to address significant unmet medical needs of patients with.
ZyVersa is a clinical stage biopharmaceutical company developing first-in-class product candidates to address significant unmet medical needs of patients with.
NEW YORK (BUSINESS WIRE) Larkspur Health Acquisition Corp. (NASDAQ: LSPRU, the “Company”) announced that the holders of the Company’s units may elect to separately trade the Class A Common Stock and redeemable warrants underlying such units commencing on February 10, 2022. Those units not separated will continue t.